PUBLISHED DATE : Dec 2019 | Pages : 233
Fill out your details & get your free sample
Medical Linear Accelerator Market Size, Share, & Trends Analysis Report by Products (equipment and software), Application (breast, prostate, lung, head and neck, colorectal cancer and others), End-users (hospitals, cancer care centers, and academic institutes and research centers), and Geography (North America, APAC, Europe, Latin America, and MEA) Industry Analysis Report, Regional Outlook, Price Trends, Competitive Market Share, Growth Potential & Forecast, 2020 – 2025
233 Pages
35 Tables
161 Charts
5 Regions
18 Countries
6 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 2.2 BILLION (2025) |
| CAGR | 7% (2020-2025) |
| BASE YEAR | 2019 |
| FOECAST YEAR | 2020-2025 |
| MARKET SEGMENTS | Products (equipment and software), Application (breast, prostate, lung, head and neck, colorectal cancer and others), End-users (hospitals, cancer care centers, and academic institutes and research centers) |
| GEOGRAPHIC ANALYSIS | North America, APAC, Europe, Latin America, and MEA |
| COUNTRIES COVERED | US, Canada, Japan, China, South Korea, Australia, India, Germany, France, UK, Spain, Italy, Brazil, Mexico, Argentina, Turkey, Saudi Arabia and UAE |
The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.
This research report includes detailed segmentation by
In 2019, breast cancer application segment accounted for 22% share of the global market. The segment is growing at a healthy with a CAGR of 8%. The rapid use of radiotherapy with medical linear accelerator equipment for the treatment of breast cancer, along with the growing incidence of these cases, is responsible for the segment growth.
The prostate segment is likely to grow at a promising CAGR during the forecast period. The segment is growing at a faster rate compared to other application segment and the trend is likely to continue during the forecast period. The primary factor driving growth includes the rise in prostate cancer worldwide. Further, the rise in the geriatric population worldwide is another key factor driving the market. Lung cancer treatment is projected to achieve maximum revenue owing to the rapid rise across the globe. Hence, the application of radiation therapy with LINAC for these treatments is likely to gain a lucrative share in the market.
The equipment segment is growing due to the growing incidence of cancers globally and the segment is expected to grow with the highest CAGR of 8.4% than software segment.
Key Advantages of Equipment
The use of innovative oncology informatics platforms has led to rapid progress in radiation treatment planning, thereby saving time and cost.
Key Advantages of LINAC Software
The hospital segment is likely to dominate the global medical linear accelerator market share. Healthcare professionals in hospitals are using LINACs as an advanced radiotherapy device for the treatment of cancer with a non-invasive procedure. The hospital segment is growing at a healthy rate and is likely to grow at a steady pace during the forecast period. The cancer care center segment is projected to grow at the highest CAGR during the forecast period. The segment will witness the highest incremental growth of around $550 million during the forecast period.
In 2019, the academic institute & research center end-users segment accounted for a 15% share of the global medical linear accelerator market. The segment is growing at a healthy rate. Moreover, the increasing number of cancer cases globally is another factor driving the growth of the segment.
North America is growing at a significant rate due to the growing preference for technologically advanced medical LINAC devices. The region is expected to witness highest incremental growth of $420 million during the forecast period. The US is the major revenue contributor in the North America region.
Europe is the second largest market and accounted for a 32% share. Germany, France, the UK, Spain, and Italy are the major revenue contributors in Europe. The market is likely to grow at a steady rate due to the growing prevalence of cancer in Europe. Breast, colorectum, lung, prostate and bladder cancers were the most common cancer cases in 2018 in the region. Due to increasing burden of cancer patient population along with the need of advanced treatment procedures, many key players are focusing on launching innovative medical linear accelerator devices in the Europe. For instance, in June 2018, world's first high-field MR-linac, Elekta Unity received CE Mark, which created a huge interest from potential customers.
The APAC market is expected to witness the highest absolute growth during the forecast period. The region has the largest population density and the highest proportion of people with cancers. China, Japan, India, Australia, and South Korea are the major revenue contributors from the region. Brazil, Mexico, and Argentina are the major revenue contributors to the medical linear accelerator market in Latin America. Although the market is growing at a moderate rate, it offers tremendous growth opportunities. Therefore, the growing need for efficient and high-quality medical care is likely to drive the growth in Latin America. Turkey, Saudi Arabia, and South Africa are the major revenue contributors to the MEA region.
The global medical LINAC market has only six vendors that provide medical linear accelerator equipment at the global and regional levels. The market is highly consolidated as the leading two vendors account for around 89% of the share. The market is witnessing rapid technological advancements and product launches. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the industry. They are investing extensively in R&D and product development activities to expand their product portfolio.
By Products
By Application
By End-users
By Geography
Frequently Asked Questions
Medical linear accelerator market size to cross revenues of over USD 2.2 billion by 2020, growing at a CAGR of over 7% during the forecast period.
Which product/application/end-user/region is growing at the fastest CAGR during the forecast period?
The equipment segment is dominating the global market and accounted for a share of 80% during the forecast period.
The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.
Who are the leading vendors in the market?
Varian Medical Systems, Elekta, and Accuray are the leading vendors.
The following factors are likely to contribute to the growth of the medical linear accelerator market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the medical linear accelerator market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspects of the market. The report profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Market Segmentation by Products
Market Segmentation by Application
Market Segmentation by End-users
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Applications
4.4.3 Market Segmentation by End-users Type
4.4.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Cancer: An Overview
7.1.1 Background
7.1.2 Radiotherapy
7.2 Medical LINACs
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Growing Prevalence of Cancer
8.1.2 Technological Advances/Innovations
8.1.3 Increasing Demand for Non-Invasive Cancer Treatment
8.2 Market Growth Restraints
8.2.1 High Costs of LINACs
8.2.2 Lack of Infrastructure & Skilled Professionals
8.2.3 Alternate Treatment Options for Cancer
8.2.4 Risks and Complications Associated with RT
8.3 Market Opportunities and Trends
8.3.1 Product Approvals/Launches
8.3.2 Emergence of MRI-Based LINACs
8.3.3 Growing Popularity of Robotic Radiotherapy
8.3.4 Integration of AI in LINACs
9 Global Medical Linear Accelerator Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Medical Linear Accelerator Market by Product Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Equipment
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.4 Software
10.4.1 Market Overview
10.4.2 Market Size & Forecast
11 Medical Linear Accelerator Market by Application
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Breast Cancer
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Prostate Cancer
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 Lung Cancer
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 Head & Neck Cancer
11.6.1 Market Overview
11.6.2 Market Size & Forecast
11.7 Colorectal Cancer
11.7.1 Market Overview
11.7.2 Market Size & Forecast
11.8 Others
11.8.1 Market Overview
11.8.2 Market Size & Forecast
12 Medical Linear Accelerator Market by End-Users
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Cancer Care Centers
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Academic Institutes & Research Centers
12.5.1 Market Overview
12.5.2 Market Size & Forecast
13 Medical Linear Accelerator Market by Geography
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Medical Linear Accelerator Market Size & Forecast
14.3.2 Canada: Market Size & Forecast
15 Europe
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Key Countries
15.3.1 Germany: Market Size & Forecast
15.3.2 UK: Medical Linear Accelerator Market Size & Forecast
15.3.3 Italy: Market Size & Forecast
15.3.4 France: Market Size & Forecast
15.3.5 Spain: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 China: Medical Linear Accelerator Market Size & Forecast
16.3.2 Japan: Market Size & Forecast
16.3.3 India: Market Size & Forecast
16.3.4 Australia: Market Size & Forecast
16.3.5 South Korea: Market Size & Forecast
17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil: Medical Linear Accelerator Market Size & Forecast
17.3.2 Mexico: Market Size & Forecast
17.3.3 Argentina: Market Size & Forecast
18 Middle East & Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey: Medical Linear Accelerator Market Size & Forecast
18.3.2 Saudi Arabia: Market Size & Forecast
18.3.3 South Africa: Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis
19.2.1 Varian Medical Systems
19.2.2 Elekta
19.2.3 Accuray
19.2.4 VIEWRAY
19.2.5 SHINVA MEDICAL INSTRUMENT
19.2.6 Panacea Medical Technologies
20 Key Vendors
20.1 Varian Medical Systems
20.1.1 Business Overview
20.1.2 Major Product Offerings
20.1.3 Key Strengths
20.1.4 Key Strategies
20.1.5 Key Opportunities
20.2 Elekta
20.2.1 Business Overview
20.2.2 Major Product Offerings
20.2.3 Key Strengths
20.2.4 Key Strategies
20.2.5 Key Opportunities
20.3 Accuray
20.3.1 Business Overview
20.3.2 Major Product Offerings
20.3.3 Key Strengths
20.3.4 Key Strategies
20.3.5 Key Opportunities
21 Other Prominent Vendors
21.1 SHINVA MEDICAL INSTRUMENT
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.1.3 Key Strengths
21.1.4 Key Strategies
21.1.5 Key Opportunities
21.2 Panacea Medical Technologies
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.2.3 Key Strengths
21.2.4 Key Strategies
21.2.5 Key Opportunities
21.3 VIEWRAY TECHNOLOGIES
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.3.3 Key Strengths
21.3.4 Key Strategies
21.3.5 Key Opportunities
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 By Product
22.3.2 By Application
22.3.3 By End-users
22.3.4 By Geography
23 Appendix
23.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Medical Linear Accelerator Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Impact of Growing Prevalence of Cancer
Exhibit 4 Global New Cancer Cases 2018 (% share)
Exhibit 5 Cancer Incidence: Segmentation by Geography 2018 (% share)
Exhibit 6 Impact of Technological Advance/Innovations
Exhibit 7 Impact of Increasing Demand for Non-Invasive Cancer Treatment
Exhibit 8 Cost Comparison of Various Cancer Treatments ($ thousands)
Exhibit 9 Global Market Opportunity for Medical LINACs
Exhibit 10 Impact of High Costs of LINACs
Exhibit 11 Impact of Lack of Infrastructure & Skilled Professionals
Exhibit 12 Distribution of Megavoltage Systems by Geography ($ share)
Exhibit 13 RT Units by Geography (per million population)
Exhibit 14 Alternate Treatment Options for Cancer
Exhibit 15 Common Side Effects of RT
Exhibit 16 Impact of Risks and Complications Associated with RT
Exhibit 17 Impact of Product Approvals/Launches
Exhibit 18 Impact of Emergence of MRI-based LINACs
Exhibit 19 Impact of Growing Popularity of Robotic Radiotherapy
Exhibit 20 Impact of Integration of AI in LINACs
Exhibit 21 Benefits of AI in LINACs
Exhibit 22 Global Medical Linear Accelerator Market: Opportunities Snapshot
Exhibit 23 Global Medical Linear Accelerator Market 2019−2025 ($ million)
Exhibit 24 Global Medical Linear Accelerator Market by Geography
Exhibit 25 Global Medical Linear Accelerator Market by Product Type
Exhibit 26 Global Medical Linear Accelerator Market by Application
Exhibit 27 Global Medical Linear Accelerator Market by End-users
Exhibit 28 Five Force Analysis 2019
Exhibit 29 Incremental Growth by Product Type 2019-2025
Exhibit 30 Market by Product Type
Exhibit 31 Market by Product: Incremental Growth
Exhibit 32 Market by Product: Absolute Growth
Exhibit 33 Market by Product 2019 & 2025 (%)
Exhibit 34 Market by Product Type 2019−2025 ($ million)
Exhibit 35 Market by Product Type 2019−2025 (% share)
Exhibit 36 Market by Equipment: Absolute & Incremental Growth
Exhibit 37 Global New Cancer Cases 2018
Exhibit 38 Global Medical Linear Accelerator Equipment Market 2019−2025 ($ million)
Exhibit 39 Global Medical Linear Accelerator Market by Software: Absolute & Incremental Growth
Exhibit 40 Global Medical Linear Accelerator Software Market 2019−2025 ($ million)
Exhibit 41 Incremental Growth by Application 2019-2025
Exhibit 42 Market by Applications
Exhibit 43 Market by Applications: Incremental Growth
Exhibit 44 Market by Applications: Absolute Growth
Exhibit 45 Market by Applications 2019 & 2025 (% share)
Exhibit 46 Market by Applications 2019−2025 ($ million)
Exhibit 47 Market by Applications 2019−2025 (% share)
Exhibit 48 Market by Breast Cancer: Absolute & Incremental Growth
Exhibit 49 Breast Cancer in Key Countries 2018 (Age Standardized Rate Per 100,000 Population)
Exhibit 50 Breast Cancer Incidence Rate: Geography 2018
Exhibit 51 Market by Breast Cancer 2019−2025 ($ million)
Exhibit 52 Market by Prostate Cancer: Absolute & Incremental Growth
Exhibit 53 Global Prostate Cancer: Age-standardized Rate per 100,000 Population 2018
Exhibit 54 Prostate Cancer Incidence: Segmentation by Geography 2018
Exhibit 55 Market by Prostate Cancer 2019−2025 ($ million)
Exhibit 56 Market by Lung Cancer: Absolute & Incremental Growth
Exhibit 57 Lung Cancer Incidence: Segmentation by Geography 2018
Exhibit 58 Market by Lung Cancer 2019−2025 ($ million)
Exhibit 59 Market by Head and Neck Cancer: Absolute & Incremental Growth
Exhibit 60 Market by Head & Neck Cancer 2019−2025 ($ million)
Exhibit 61 Market by Colorectal Cancer: Absolute & Incremental Growth
Exhibit 62 Colorectal Cancer Incidence Rate by Geography 2018
Exhibit 63 Market by Colorectal Cancer 2019−2025 ($ million)
Exhibit 64 Market by Other Cancers: Absolute & Incremental Growth
Exhibit 65 Global Newly Diagnosed Cancer Cases 2018
Exhibit 66 Market by Other Cancers 2019−2025 ($ million)
Exhibit 67 Incremental Growth by End-users 2019-2025
Exhibit 68 Global Medical LINACs Market by End-users
Exhibit 69 Market by End-users: Absolute Growth
Exhibit 70 Market by End-users: Incremental Growth
Exhibit 71 Market by End-users 2019 & 2025 (% share)
Exhibit 72 Market by End-users 2019−2025 ($ million)
Exhibit 73 Market by End-Users 2019−2025 (% share)
Exhibit 74 Market by Hospitals: Absolute & Incremental Growth
Exhibit 75 Market by Hospitals 2019−2025 ($ million)
Exhibit 76 Market by Cancer Care Centers: Absolute & Incremental Growth
Exhibit 77 Market by Cancer Care Centers 2019−2025 ($ million)
Exhibit 78 Market by Academic Institutes & Research Centers: Absolute & Incremental Growth
Exhibit 79 Market by Academic Institutes & Research Centers 2019−2025 ($ million)
Exhibit 80 Incremental Growth by Geography 2019-2025
Exhibit 81 Global Medical LINACs Market by Geography
Exhibit 82 Market by Geography 2019 ($ million)
Exhibit 83 Market by Geography: Absolute Growth
Exhibit 84 Market by Geography: Incremental Growth
Exhibit 85 Market by Geography 2019 & 2025 (%)
Exhibit 86 Market by Geography 2019−2025 ($ million)
Exhibit 87 Market by Geography 2019−2025 (%)
Exhibit 88 Medical Linear Accelerator Market in North America: Key Countries 2019
Exhibit 89 Market in North America: Absolute & Incremental Growth
Exhibit 90 New Cancer Cases in North America 2018
Exhibit 91 Market in North America 2019−2025 ($ million)
Exhibit 92 Incremental Growth in North America 2019−2025
Exhibit 93 Number of New Cancer Cases in US 2018
Exhibit 94 Market in US 2019−2025 ($ million)
Exhibit 95 New Cancer Cases in Canada 2018
Exhibit 96 Market in Canada 2019−2025 ($ million)
Exhibit 97 Medical LINACs Market in Europe: Key Countries 2019
Exhibit 98 Europe Medical Linear Accelerator Market: Absolute & Incremental Growth
Exhibit 99 Number of New Cancer Cases in Europe 2018
Exhibit 100 Number of New Cancer Cases in Men in Europe 2018
Exhibit 101 Number of New Cancer Cases in Women in Europe 2018
Exhibit 102 Market in Europe 2019–2025 ($ million)
Exhibit 103 Incremental Growth in Europe 2019-2025
Exhibit 104 Number of New Cancer Cases in Men & Women 2018
Exhibit 105 Market in Germany 2019–2025 ($ million)
Exhibit 106 Number of New Cancer Cases in UK 2018
Exhibit 107 Market in UK 2019–2025 ($ million)
Exhibit 108 Number of New Cancer Cases in Ital 2018
Exhibit 109 Market in Italy 2019–2025 ($ million)
Exhibit 110 Number of New Cancer Cases in France 2018
Exhibit 111 Market in France 2019–2025 ($ million)
Exhibit 112 Number of New Cancer Cases in Spain 2018
Exhibit 113 Market in Spain 2019–2025 ($ million)
Exhibit 114 Medical Linear Accelerator Market in APAC: Key Countries 2019
Exhibit 115 Market in APAC: Absolute & Incremental Growth
Exhibit 116 Number of New Cancer Cases in APAC 2018
Exhibit 117 Number of New Cancer Cases in APAC in Men 2018
Exhibit 118 Number of New Cancer Cases in APAC in Women 2018
Exhibit 119 Market in APAC 2019–2025 ($ million)
Exhibit 120 Incremental Growth in APAC 2019-2025
Exhibit 121 New cancer Cases in China 218
Exhibit 122 Market in China 2019–2025 ($ million)
Exhibit 123 New Cancer Cases in Japan 2018
Exhibit 124 Market in Japan 2019–2025 ($ million)
Exhibit 125 Number of New Cancer Cases in India 2018
Exhibit 126 Market in India 2019–2025 ($ million)
Exhibit 127 Number of New Cancer Cases in Australia 2018
Exhibit 128 Market in Australia 2019–2025 ($ million)
Exhibit 129 Number of New Cancer Cases in Korea 2018
Exhibit 130 Market in South Korea 2019–2025 ($ million)
Exhibit 131 Medical Linear Accelerator Market in Latin America: Key Countries 2019
Exhibit 132 Market in Latin America: Absolute & Incremental Growth
Exhibit 133 Number of New Cancer Cases in Latin America 2018
Exhibit 134 Number of New Cancer Cases in Latin America in Men 2018
Exhibit 135 Number of New Cancer Cases in Latin America in Women 2018
Exhibit 136 Market in Latin America 2019–2025 ($ million)
Exhibit 137 Incremental Growth in Latin America 2019-2025
Exhibit 138 Number of New Cancer cases in Brazil 2018
Exhibit 139 Market in Brazil 2019–2025 ($ million)
Exhibit 140 Number of New Cancer Cases in Mexico 2018
Exhibit 141 Market in Mexico 2019–2025 ($ million)
Exhibit 142 Number of New Cancer Cases in Argentina 2018
Exhibit 143 Market in Argentina 2019–2025 ($ million)
Exhibit 144 Medical Linear Accelerator Market in MEA 2019
Exhibit 145 Market in MEA: Absolute & Incremental Growth
Exhibit 146 Number of New Cancer Cases in Africa 2018
Exhibit 147 Market in MEA 2019–2025 ($ million)
Exhibit 148 Incremental Growth in MEA 2019-2025
Exhibit 149 Number of New Cancer Cases in Turkey 2018
Exhibit 150 Market in Turkey 2019–2025 ($ million)
Exhibit 151 Number of New Cancer Cases in Saudi Arabia 2018
Exhibit 152 Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 153 Number of New Cancer Cases in South Africa 2018
Exhibit 154 Market in South Africa 2019–2025 ($ million)
Exhibit 155 Global Medical Linear Accelerators Market: Key Vendors (% share)
Exhibit 156 Varian Medical Systems: R&D Expenditure 2016−2018 ($ million)
Exhibit 157 Varian Medical Systems: Revenue by Segments
Exhibit 158 Elekta: Revenue by Geography
Exhibit 159 Elekta: R&D Expenditure 2017−2019 ($ million)
Exhibit 160 Elekta: Revenue Breakdown by Geography
Exhibit 161 Accuray: Revenue Breakdown by Geography FY2019 (% share)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Technologically Advanced Medical LINACs by Key Players
Table 4 Approximate Cost of LINAC Systems
Table 5 Average Procedural Cost of Lung Cancer Radiotherapy with SBRT ($ thousands)
Table 6 Global Estimated Trends in Cancer Incidence 2010-2030
Table 7 Crude Cancer Incidence in LMICs
Table 8 Key Advantages of Other Available Treatment Options for Cancer
Table 9 Treatment Areas and Possible Side-effects of RT
Table 10 Recent Product Approvals and Launches in Global Medical Linear Accelerator Market
Table 11 Medical LINACs from Key Market Players
Table 12 LINAC Compatible Software by Key Market Players
Table 13 LINACs for Breast Cancer by Players
Table 14 Medical LINAC for Prostate Cancer by Players
Table 15 Medical LINACs for Lung Cancer by Players
Table 16 Medical LINACs for Head & Neck Cancer by Players
Table 17 Prominent Cancer Care Centers Around the World
Table 18 Prominent Academic Institutes & Research Centers
Table 19 CMS Approved New Rates in US 2018
Table 20 Estimated Number of LINACs in Key European Countries
Table 21 Global Medical Linear Accelerator Market: Top Vendors Ranking
Table 22 Varian Medical Systems: Key Product Offerings
Table 23 Elekta: Key Product Offerings
Table 24 Accuray: Key Product Offerings
Table 25 SHINVA MEDICAL INSTRUMENT: Key Product Offerings
Table 26 Panacea Medical Technologies: Key Product Offerings
Table 27 VIEWRAY TECHNOLOGIES: Key Product Offerings
Table 28 Global Market by Products ($ million)
Table 29 Global Market by Products (% share)
Table 30 Global Market by Application ($ million)
Table 31 Global Market by Applications (% share)
Table 32 Global Market by End-users ($ million)
Table 33 Global Market by End-users (% share)
Table 34 Global Market by Geography ($ million)
Table 35 Global Market by Geography (% share)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
